Boundless Bio, Inc. (BOLD) vs Dogwood Therapeutics, Inc. (DWTX)
A side-by-side comparison of Boundless Bio, Inc. and Dogwood Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLD
Boundless Bio, Inc.
$2.61HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
DWTX
Dogwood Therapeutics, Inc.
$1.56HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — BOLD vs DWTX
growth of $100 · dividends reinvested · last 3yBOLD -81.8% (-43.3%/yr)DWTX -87.4% (-49.9%/yr)BOLD compounded faster over this window
BOLD DWTX
BOLD vs DWTX: by the numbers
- •BOLD is the larger company ($59M vs $52M market cap).
Metrics side by side
Valuation
| Metric | BOLD | DWTX |
|---|---|---|
| P/B ratio | 0.89 | 0.77 |
Profitability
| Metric | BOLD | DWTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -58.99% | -52.72% |
| ROIC | -43.97% | -38.04% |
Growth (annualized)
| Metric | BOLD | DWTX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -58.44% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.